Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM), and pregnancy is well known to accentuate it.\[[@ref1][@ref2][@ref3]\] Numerous studies have been done in developed nations and progression of DR during pregnancy has been documented very well.\[[@ref4][@ref5][@ref6][@ref7]\] In some cases, DR can accelerate quickly to advanced stages requiring surgery. For these reasons, screening protocols have been developed for sequential observation of pregnant females with DM, though these are not universal and are surrounded by controversies.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7]\] The presence of retinopathy has also been analyzed for its association with poor outcomes of pregnancy.\[[@ref7][@ref8][@ref9][@ref10]\] However, majority of these studies have been done in developed countries where primordial and primary prevention is much better as compared to a developing nation. The current study has been done in the perspective of a developing nation. We have aimed to evaluate the prevalence of DR in mothers with pregestational DM, the incidence of new-onset DR during gestation, and the clinical course and associated risk factors for DR in such cases.

Methods {#sec1-2}
=======

This is an ambispective observational cohort study conducted at a tertiary eye care center of Northern India between June 2015 and January 2017. The study was approved by the Institute Ethics committee (IECPG-72/27.11.2015), and written informed consent was obtained from all the patients.

A total of 50 pregnant diabetic females were evaluated during and after pregnancy for the presence and progression of DR. These patients were recruited from the departments of obstetrics and gynecology, endocrinology, and ophthalmology. All the cases had preexisting DM before the current pregnancy, while those with gestational DM were excluded from the study.

History with regard to age of onset of diabetes and control of diabetes was recorded. Body mass index, blood pressure (systolic and diastolic), hemoglobin, glycated hemoglobin (HbA1c), renal function tests (blood urea and creatinine), proteinuria, fasting and postprandial blood glucose values values were noted for all the females at presentation, during each of the 3 trimesters and 3 months postpartum \[[Table 1](#T1){ref-type="table"}\]. Following childbirth, fetal data were obtained for birth weight, Apgar score at birth, and presence of any fetal defects. Ocular examination was carried out at presentation, during each of the 3 trimesters and 3 months postpartum. Visual acuity was noted, and dilated fundus examination and clinical fundus photography (VISUCAM 500 ZEISS, Germany) were done. DR and its progression were graded according to the early treatment of DR study classification. If the patient had proliferative DR (PDR), standard pan-retinal laser photocoagulation was undertaken promptly.
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Risk factors for diabetic retinopathy
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The main outcome measures were prevalence and progression of DR. Risk factors for DR, and maternal and fetal outcomes were also analyzed. Statistical analysis was performed after compilation of data using software Stata 14.0 (StataCorp LLC, USA). Arithmetic mean, standard deviation (SD), and frequency distribution were calculated for all the descriptive parameters. Categorical variables were summarized as frequency (%). Quantitative variables were summarized as mean ± SD or median. Cases with DR were compared with those without retinopathy. For nonparametric data, Wilcoxon rank-sum test (Mann--Whitney test) was applied for analysis. Chi-square test/Fischer exact test was used to analyze two categorical variables. A two-tailed *P* \< 0.001 was considered statistically significant.

Results {#sec1-3}
=======

In this study, 23 patients were enrolled prospectively while retrospective data were obtained in some form from 27 patients. Nineteen (38%) were primigravid. Median age at conception was 29 years. Mean duration of diabetes was 4.28 years. Three cases (6%) had Type I DM, and 47 (94%) had Type II DM. All patients with type 1 diabetes had some form of DR. In patients with Type 2 DM, only 1 patient (2.13%) was noted to have DR during the study period. Twenty-six diabetic mothers were insulin dependent, and four of these developed DR. The overall prevalence of DR during the study was determined to be 8% (*n* = 4).

Progression of diabetic retinopathy and visual outcomes {#sec2-1}
-------------------------------------------------------

Four patients were detected to have DR at presentation, of which two had nonproliferative DR (NPDR) and two had PDR. The disease was always bilateral. Both patients with PDR worsened during pregnancy and 1 of these developed severe fibrovascular proliferation with vitreous hemorrhage and underwent surgery \[[Fig. 1](#F1){ref-type="fig"}\]. Mean visual acuity in eyes with NPDR was 0.0 logMAR units at presentation and final follow-up. Mean visual acuity in eyes with PDR was 0.77 ± 0.83 logMAR units at presentation and 1.45 ± 1.28 logMAR units at final follow-up (1 patient underwent surgery in left eye). Three months after the pregnancy, DR did not spontaneously regress in any patient.

![(a) Fundus photograph of the left eye of Case 3 \[details in [Table 2](#T2){ref-type="table"}\] showing aggressive nasal fibrovascular frond with tractional retinal detachment. (b) Postlaser photocoagulation fundus picture of the eye in Figure 1a shows regression of the front. (c) Intraoperative photograph of the left eye of Case 4 \[details in [Table 2](#T2){ref-type="table"}\] after core vitrectomy showing tense fibrotic bands with underlying subhyaloid hemorrhage. (d) Postoperative photograph of the same eye as in Figure 1c showing attached retina, laser spots, and silicone oil *in situ*](IJO-66-541-g002){#F1}

Risk factors for diabetic retinopathy {#sec2-2}
-------------------------------------

Baseline parameters of mothers with and without DR are depicted in [Table 2](#T2){ref-type="table"}. The median age at conception was 31 years and 29 years in the group with DR and without respectively (*P* = 0.3231). The mean duration of diabetes was 14 ± 6.32 years in patients with DR whereas in patients without DR, the mean duration of diabetes was 3.43 ± 1.43 years. *P* value was statistically significant (*P* = 0.0008), and thus there was a strong association between the duration of DM and the presence of DR. There was no significant association of the presence of DR with the gravida, number of live births, and previous history of abortions. Systemic parameters were compared between these patients separately for all the trimesters. The diastolic blood pressure was found to have a significant association with presence of DR in the third trimester (*P* = 0.0017) while the rest of the parameters did not have significant association \[[Table 1](#T1){ref-type="table"}\]. Nearly 44% of the cases also had concurrent pregnancy-induced hypertension (*n* = 22/50). There was no association (*P* = 0.1052) between HbA1c before conception and presence of DR. However, the mean value of HbA1c was higher in the group with DR.
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Maternal and fetal outcomes {#sec2-3}
---------------------------

Eight patients had either an abortion or a pregnancy loss. In mothers without retinopathy, full-term delivery, preterm delivery, intrauterine death, and abortions were noted in 77.9%, 4.4%, 6.7%, and 11.1%, respectively. In patients with DR (*n* = 4), 2 had full-term delivery, 1 had preterm delivery, and 1 had abortion. Outcomes in patients with DR have been summarized in [Table 2](#T2){ref-type="table"}.

Discussion {#sec1-4}
==========

In this study, the overall prevalence of DR was 8% (4/50); 2 cases had NPDR while 2 had PDR. Worsening was seen in both the patients with PDR, whereas patients with NPDR remained stable. None of the patients with NPDR converted to PDR. Assessment of risk factors for DR revealed significantly higher duration of DM in patients with worsening of PDR during pregnancy. Higher diastolic blood pressure was found in the last trimester in patients with DR. Spontaneous resolution was not noted in any of the patients.

Worsening of DR during pregnancy is well documented in women with pregestational DM.\[[@ref11]\] Most of the previously done studies on progression of DR in such cases have been done in developed nations and show high rates of progression of retinopathy.\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27]\] To the best of our knowledge, this is the first study on DR in pregnancy from a low-middle income country.

Unlike in the past, recent studies show lesser progression rates \[bottom half of [Table 3](#T3){ref-type="table"}\]. The cohorts analyzed in most of the previous studies has chiefly comprised of either type 1 DM or insulin dependent patients \[[Table 3](#T3){ref-type="table"}\].\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24][@ref25][@ref26][@ref27]\] In our study, nearly half (22/50) were insulin dependent, and only 3/50 had type 1 DM. We analyzed these factors for their OR of association with DR and found Type 1 cases and insulin-dependent cases to have higher OR though the CI was large. Omori *et al*. conducted a study on 207 deliveries comprising both the types of DM cases in Japan and found 10% of insulin-dependent cases to have PDR while only 4% of noninsulin dependent cases developed PDR.\[[@ref28]\] On the other hand, Egan *et al*. evaluated 185 patients and did not find type or duration of DM to have a significant effect on the development of DR in a logistic regression model.\[[@ref27]\] In our study, however, duration of DM was found to have a significant impact on the development of DR \[[Table 1](#T1){ref-type="table"}\].
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The prevalence of retinopathy reported in diabetic pregnancies is 10%--27%,\[[@ref29]\] while in our study, it was found to be 8%. DR is influenced by multiple factors including the pregnancy itself, glycemic control before and during pregnancy, and the presence of previous retinopathy. Maternal complications such as pregnancy-induced hypertension, diabetic nephropathy, and preeclampsia are also associated with progression of retinopathy.\[[@ref20][@ref28][@ref30]\] A major challenge to improving outcomes is to ensure optimal glycemic control at the time of conception and to maintain this throughout the pregnancy.\[[@ref31][@ref32]\] Systemic factors were well controlled in most of our patients, and it can be seen in [Table 2](#T2){ref-type="table"} that patients with poor control and PDR fared the worst in our cohort. Hence, patients with advanced forms of preexisting DR and those with poor systemic control should be evaluated more frequently by the ophthalmologist during pregnancy. In this regard, recommendations for retinopathy screening and management in pregnancy vary significantly. The American Diabetes Association advises an eye examination in the first trimester with close follow-up throughout pregnancy.\[[@ref10]\] The National Institute for Health and Clinical Excellence in the United Kingdom recommends retinal assessment following the first antenatal clinic appointment and again at 28 weeks if the first assessment is normal. If any DR is present, an additional retinal assessment should be performed at 16--20 weeks.\[[@ref31]\] Perhaps, regional data as provided by this study should be taken into account and local screening guidelines should be developed.

Before the advent of laser photocoagulation, proliferative retinopathy was a contraindication to pregnancy because of the substantial risk of severe visual loss, so that women with diabetes who became pregnant were advised to consider termination.\[[@ref33]\] With the use of laser photocoagulation and the establishment and recognition of high-risk characteristics,\[[@ref34]\] the likelihood of visual loss has been reduced. Appropriate treatment of preexisting PDR with photocoagulation before pregnancy may protect against rapidly progressive PDR during pregnancy. A study of patients with proliferative retinopathy detected in early pregnancy and subsequently treated by laser showed that 58% experienced significant progression and visual loss. On the other hand, only 26% of patients in whom retinopathy was diagnosed and treated before the onset of pregnancy showed the progression of retinopathy during an ensuing gestation.\[[@ref35]\] In the study by Rahman *et al*., in three out of the four patients who received laser treatment for PDR before pregnancy, the retinopathy remained stable throughout pregnancy.\[[@ref23]\] The fourth patient with the progression of retinopathy required further laser treatment and responded well, maintaining good vision. The number of patients with PDR that were treated before pregnancy in the study was too small to draw any valid conclusions regarding the benefits of treatment. In the study by Temple *et al*., only four women (2.2% pregnancies) required laser therapy for the development of proliferative retinopathy.\[[@ref22]\] However, in our study, 50% of the patients with DR had established PDR and worsened despite laser.

In our study, as stated prior, duration of diabetes was found to be significantly associated with DR. The median age at conception was also higher in the group with DR, though this result was not statistically significant. We believe that there is an urgent need to promote early pregnancy planning among women with DM for optimal visual outcomes. Specialized prepregnancy clinics and multidisciplinary antenatal clinics should aim to address this rather than only aiming for good systemic control. Similar suggestions have also been made previously.\[[@ref18]\]

Limitations {#sec2-4}
-----------

As the number of patients with DR was too small in our study, it is possible that the results regarding risk factors could have been underestimated. Further, all the patients in the prospective group could not be seen before pregnancy for assessment of baseline retinopathy. In addition, the numbers of patients with retinopathy were less to analyze associated risk of abortion and poor fetal outcomes. However, as per our findings, perhaps young women with long-standing DM require timely counseling and complete ocular examination before conception. In the presence of severe DR, there may be a need to defer pregnancy until retinopathy is adequately controlled (with prompt treatment). Advocacy and counseling regarding the benefits of completing the family early in young women with diabetes is a concern that needs to be addressed with appropriately designed larger sized evaluations. It has been previously also seen that natural course of DM impacts the visual outcomes and that longer duration of DM and older age at the examination is associated with severity of retinopathy in younger-onset diabetic patients.\[[@ref36]\] Extrapolating these findings to our subset of patients may simply reflect that pregnancy is a risk factor for worsening of the disease and worsening is most likely to occur in patients with long-standing DM.

Conclusion {#sec1-5}
==========

To summarize, pregnant females with PDR and those with long duration of preexisting DM should be carefully monitored during pregnancy. PDR should be treated as early possible. Guidelines need to be developed for managing the pregnancy in women with untreated and advanced PDR. Our findings raise the issue of poor visual outcomes in older pregnant females with long-standing DM, and we recommend the development of a separate national registry and referral system for all young women with diabetes.
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